MedPath

广东省惠州市中药厂有限公司

Ownership
-
Established
1990-01-18
Employees
-
Market Cap
-
Website
http://www.hzszyc.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

41

NMPA:41

Drug Approvals

复方穿心莲片

Approval Number
国药准字Z44021867
Approval Date
May 14, 2024
NMPA

壮腰健肾片

Approval Number
国药准字Z44021891
Approval Date
May 14, 2024
NMPA

腹可安片

Approval Number
国药准字Z44021871
Approval Date
May 14, 2024
NMPA

喉痛灵片

Approval Number
国药准字Z44021876
Approval Date
May 14, 2024
NMPA

复方鱼腥草片

Approval Number
国药准字Z44021870
Approval Date
Apr 26, 2024
NMPA

黄柏胶囊

Approval Number
国药准字Z44021878
Approval Date
Apr 26, 2024
NMPA

感冒清胶囊

Approval Number
国药准字Z44022184
Approval Date
Apr 26, 2024
NMPA

莲芝消炎胶囊

Approval Number
国药准字Z44022186
Approval Date
Apr 26, 2024
NMPA

抗骨增生片

Approval Number
国药准字Z44021879
Approval Date
Apr 26, 2024
NMPA

护肝片

Approval Number
国药准字Z44021877
Approval Date
Apr 26, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.